SPOP 是病理性心脏缩和心脏衰竭的关键触发因素
Hao Wu1,2, Yuting Zhuang1,3, Ying Yue1
1State Key Laboratory of Frigid Zone Cardiovascular Diseases, Department of Pharmacology, College of Pharmacy, Harbin, Heilongjiang, P.R. China (H.W., Y. Zhuang, Y. Yue, Jiangqi Liu, J.H., Y. Yao, Junwu Liu, Y. Li, Z.Y., Y.W., W.Y., B.M., X.H., Z.T., Y. Yang, Jialiang Li, Y. Zhang, B.Y., Z.P., Y. Lu).
Circulation research
|September 15, 2025
概括
斑点型POZ蛋白 (SPOP) 通过降解自调节器TFEB驱动心脏缩和心力衰竭. 抑制SPOP为心力衰竭提供了一个潜在的治疗策略.
科学领域:
- 心血管生物学 心血管生物学
- 疾病的分子机制.
- 蛋白质降解途径 蛋白质降解途径
背景情况:
- 蛋白质的合成和降解在生物和病理过程中至关重要.
- 斑点类型的POZ蛋白 (SPOP),E3泛素酶适配器,与癌症进展有关.
- 在心脏缩和心力衰竭中SPOP的作用需要研究.
研究的目的:
- 阐明心脏缩和心力衰竭中SPOP的生物学功能和潜在机制.
- 评估针对心脏病中的SPOP的治疗潜力.
主要方法:
- 产生心脏特异性转基因和淘汰赛小鼠模型.
- 通过横向大动脉收缩诱导心脏缩.
- 应用RNA测序,蛋白质组学和分子生物学技术.
- 在实验室研究中,使用新生小鼠腹腔心肌细胞接受安二醇治疗.
主要成果:
- 在人类和小鼠心力衰竭中,SPOP被上调,并促进了多变性标记物和心肌细胞大小.
- 特定于心脏的SPOP过度表达会诱发缩和心力衰竭;SPOP缺乏会减轻这些情况.
- SPOP促进TFEB降解,抑制自和小,导致心脏病理.
- 过度表达TFEB可以挽救SPOP诱导的变化,而SPOP抑制可以防止心脏缩.
结论:
- 通过降解TFEB,即自-溶酶体通路的关键调节剂,SPOP加剧了病态心脏缩.
- 准SPOP是一个有前途的治疗策略,用于与增大相关的心力衰竭.
相关概念视频
Heart Failure II: Pathophysiology
734
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
734
Pathophysiology of Heart Failure
3.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.0K
Heart Failure I: Introduction
710
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
710
Mitral Regurgitation I: Introduction
423
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
423
Cardiomyopathy III: Hypertrophic Cardiomyopathy
414
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
414
Hypertension II: Pathophysiology
803
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
803


